Koers SMS Pharmaceuticals Limited Bombay S.E.
Aandelen
SMSPHARMA
INE812G01025
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
209,6 INR | +6,56% | +2,49% | +76,70% |
Omzet 2022 | 5,2 mld. 62,31 mln. 57,91 mln. | Omzet 2023 | 5,22 mld. 62,57 mln. 58,15 mln. | Marktkapitalisatie | 4,93 mld. 59,1 mln. 54,93 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 622 mln. 7,45 mln. 6,93 mln. | Nettowinst (verlies) 2023 | -70 mln. -839K -780K | EV/omzet 2022 | 1,94 x |
Nettoschuld 2022 | 2,17 mld. 25,97 mln. 24,14 mln. | Nettoschuld 2023 | 2,47 mld. 29,57 mln. 27,48 mln. | EV/omzet 2023 | 1,42 x |
K/w-verhouding 2022 |
12,7
x | K/w-verhouding 2023 |
-69,9
x | Werknemers | 1.095 |
Dividendrendement 2022 |
0,32% | Dividendrendement 2023 |
0,52% | Vrij verhandelbaar | 27,62% |
1 dag | +6,56% | ||
1 week | +2,49% | ||
Lopende maand | +2,49% | ||
1 maand | +1,97% | ||
3 maanden | +60,34% | ||
6 maanden | +73,70% | ||
Lopend jaar | +76,70% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 63 | 30-08-90 | |
Director of Finance/CFO | - | 13-09-17 | |
Tirumalesh Tumma
CMP | Compliance Officer | - | 16-02-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 63 | 30-08-90 | |
Director/Board Member | 60 | 12-08-19 | |
Director/Board Member | 67 | 12-08-14 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
07-05-24 | 209,6 | +6,56% | 227 726 |
06-05-24 | 196,8 | -2,07% | 64 095 |
03-05-24 | 200,9 | -2,24% | 107 382 |
02-05-24 | 205,5 | +0,46% | 78 681 |
30-04-24 | 204,6 | -1,26% | 40 899 |
uitgestelde koers Bombay S.E., 07 mei 2024 om 12:17 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+20,32% | 43,95 mld. | |
+22,22% | 22,49 mld. | |
+11,68% | 14,71 mld. | |
+11,31% | 13,77 mld. | |
+42,32% | 12,3 mld. | |
-8,70% | 7,03 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+12,33% | 5,48 mld. |
- Beurs
- Aandelen
- Koers SMSPHARMA
- Koers SMSPHARMA